BioMarin resubmits haemophilia A gene therapy to the EMA

29th June 2021 Uncategorised 0

Company initially withdrew a marketing authorisation application for the gene therapy last year

More: BioMarin resubmits haemophilia A gene therapy to the EMA
Source: News